Eramox 400 mg is a synthetic, broad-spectrum antibiotic belonging to the fluoroquinolone class. It exhibits potent activity against a wide range of gram-positive, gram-negative, anaerobic, and atypical bacteria, including Mycoplasma pneumoniae. Eramox functions by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and repair, thereby preventing bacterial proliferation